Reflecting this important role in signaling, dysregulated ADAM17 activity is linked to many human diseases, including immunodeficiency, inflammatory bowel disease, rheumatic arthritis, cancer, and Alzheimer's disease. This evidence concerns the gene ADAM17 and early-onset autosomal dominant Alzheimer disease.